Document is current
Any future updates will be listed below
-
Authors
Hoebel, Katharina V.
Lindsay, James R.
Altreuter, Jennifer
Alessi, Joao V.
Weirather, Jason L.
Dryg, Ian
Giobbie-Hurder, Anita
Li, Zhirou
Yu, Kun-Hsing
Awad, Mark M.
Rodig, Scott J.
Lotter, William
-
Funding
Funding for this research was provided by:
National Cancer Center
National Institute of General Medical Sciences (R35GM142879)
U.S. Department of Defense (HT9425-231-0523)
American Cancer Society (RSG-24-1253761-01-ESED)
Ellison Foundation
Wong Family Award in Translational Oncology
National Institute of Biomedical Imaging and Bioengineering (R21EB035247)
U.S. National Library of Medicine (R01LM014775)
- License Information
-
More Information
Article History
Received: 18 July 2025
Accepted: 27 January 2026
First Online: 7 March 2026
Competing interests
: S.R. is on the SAB of Immunitas Therapeutics. S.R. receives research funding from Bristol-Myers-Squibb, KITE/Gilead, and Coherus Therapuetics. All other authors report no conflicts of interest.
